HAVN Life Sciences Inc. announced that Mr. Gordon Clissold is departing as CFO of the Company. With Mr. Clissold's departure, Mr. Tim Moore, Chairman and CEO, assumes the role of Interim CFO.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 CAD | -.--% | +20.00% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 632K | |
+33.37% | 49.46B | |
+1.55% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.57% | 26.61B | |
-21.00% | 18.64B | |
+7.36% | 13.16B | |
+28.30% | 12.55B | |
+23.80% | 12.1B |
- Stock Market
- Equities
- HAVN Stock
- News HAVN Life Sciences Inc.
- HAVN Life Sciences Inc. Announces CFO Changes